Cubist Systematic Strategies’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-36,181
| Closed | -$4.12M | – | 3640 |
|
|
2022
Q4 | $4.12M | Sell |
36,181
-61,529
| -63% | -$7M | 0.02% | 813 |
|
|
2022
Q3 | $6.05M | Sell |
97,710
-8,339
| -8% | -$516K | 0.03% | 680 |
|
|
2022
Q2 | $8.46M | Buy |
106,049
+16,513
| +18% | +$1.32M | 0.05% | 442 |
|
|
2022
Q1 | $9.42M | Buy |
89,536
+9,198
| +11% | +$968K | 0.08% | 329 |
|
|
2021
Q4 | $8.66M | Buy |
80,338
+11,262
| +16% | +$1.21M | 0.08% | 315 |
|
|
2021
Q3 | $7.57M | Buy |
69,076
+56,179
| +436% | +$6.15M | 0.1% | 281 |
|
|
2021
Q2 | $1.21M | Buy |
12,897
+184
| +1% | +$17.2K | 0.01% | 1430 |
|
|
2021
Q1 | $1.17M | Buy |
+12,713
| New | +$1.17M | 0.02% | 1429 |
|
|
2020
Q4 | – | Sell |
-173,262
| Closed | -$13.5M | – | 2817 |
|
|
2020
Q3 | $13.5M | Buy |
173,262
+138,305
| +396% | +$10.7M | 0.2% | 70 |
|
|
2020
Q2 | $1.94M | Sell |
34,957
-3,800
| -10% | -$211K | 0.03% | 810 |
|
|
2020
Q1 | $1.15M | Buy |
38,757
+26,957
| +228% | +$798K | 0.03% | 748 |
|
|
2019
Q4 | $427K | Sell |
11,800
-79,280
| -87% | -$2.87M | 0.01% | 1640 |
|
|
2019
Q3 | $2.48M | Sell |
91,080
-127,049
| -58% | -$3.46M | 0.05% | 536 |
|
|
2019
Q2 | $5.25M | Buy |
218,129
+8,999
| +4% | +$217K | 0.1% | 287 |
|
|
2019
Q1 | $5.53M | Buy |
+209,130
| New | +$5.53M | 0.18% | 107 |
|
|
2018
Q4 | – | Sell |
-25,222
| Closed | -$494K | – | 2399 |
|
|
2018
Q3 | $494K | Buy |
25,222
+11,952
| +90% | +$234K | 0.03% | 822 |
|
|
2018
Q2 | $220K | Sell |
13,270
-61,464
| -82% | -$1.02M | 0.01% | 1288 |
|
|
2018
Q1 | $1.06M | Sell |
74,734
-8,519
| -10% | -$121K | 0.06% | 405 |
|
|
2017
Q4 | $1.22M | Buy |
83,253
+33,760
| +68% | +$493K | 0.06% | 391 |
|
|
2017
Q3 | $628K | Buy |
49,493
+44,433
| +878% | +$564K | 0.04% | 678 |
|
|
2017
Q2 | $60K | Sell |
5,060
-11,713
| -70% | -$139K | ﹤0.01% | 1522 |
|
|
2017
Q1 | $248K | Sell |
16,773
-862
| -5% | -$12.7K | 0.02% | 1037 |
|
|
2016
Q4 | $285K | Sell |
17,635
-19,240
| -52% | -$311K | 0.02% | 991 |
|
|
2016
Q3 | $669K | Sell |
36,875
-39,545
| -52% | -$717K | 0.04% | 587 |
|
|
2016
Q2 | $1.26M | Buy |
76,420
+60,920
| +393% | +$1M | 0.07% | 357 |
|
|
2016
Q1 | $257K | Sell |
15,500
-356
| -2% | -$5.9K | 0.01% | 1074 |
|
|
2015
Q4 | $344K | Sell |
15,856
-110,450
| -87% | -$2.4M | 0.02% | 1039 |
|
|
2015
Q3 | $2.5M | Buy |
126,306
+46,306
| +58% | +$918K | 0.13% | 177 |
|
|
2015
Q2 | $2.78M | Buy |
80,000
+70,840
| +773% | +$2.46M | 0.14% | 182 |
|
|
2015
Q1 | $238K | Buy |
9,160
+1,446
| +19% | +$37.6K | 0.01% | 1414 |
|
|
2014
Q4 | $99K | Buy |
7,714
+3,814
| +98% | +$48.9K | 0.01% | 1696 |
|
|
2014
Q3 | $48K | Buy |
+3,900
| New | +$48K | ﹤0.01% | 1639 |
|